Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma

被引:72
|
作者
Landwehr, Laura-Sophie [1 ]
Altieri, Barbara [1 ]
Schreiner, Jochen [1 ]
Sbiera, Iuliu [1 ]
Weigand, Isabel [1 ]
Kroiss, Matthias [1 ,2 ]
Fassnacht, Martin [1 ,2 ,3 ]
Sbiera, Silviu [1 ,2 ]
机构
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany
[2] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany
关键词
immunity; immunotherapy; lymphocytes; tumor-infiltrating; t-lymphocytes; tumor microenvironment; REGULATORY T-CELLS; EUROPEAN-SOCIETY; PHASE-II; CANCER; COLLABORATION; PEMBROLIZUMAB; MANAGEMENT; NIVOLUMAB; SURVIVAL; EFFICACY;
D O I
10.1136/jitc-2019-000469
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in similar to 60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize tumor-infiltrating T lymphocytes (TILs) in ACC in association with glucocorticoids as potential explanation for resistance to immunotherapy. Methods We performed immunofluorescence analysis to visualize tumor-infiltrating T cells (CD3(+)), T helper cells (CD3(+)CD4(+)), cytotoxic T cells (CD3(+)CD8(+)) and regulatory T cells (Tregs; CD3(+)CD4(+)FoxP3(+)) in 146 ACC tissue specimens (107 primary tumors, 16 local recurrences, 23 metastases). Quantitative data of immune cell infiltration were correlated with clinical data (including glucocorticoid excess). Results 86.3% of ACC specimens showed tumor infiltrating T cells (7.7 cells/high power field (HPF)), including T helper (74.0%, 6.7 cells/HPF), cytotoxic T cells (84.3%, 5.7 cells/HPF) and Tregs (49.3%, 0.8 cells/HPF). The number of TILs was associated with better overall survival (HR for death: 0.47, 95% CI 0.25 to 0.87), which was true for CD4(+)- and CD8(+) subpopulations as well. In localized, non-metastatic ACC, the favorable impact of TILs on overall and recurrence-free survival was manifested even independently of ENSAT (European Network for the Study of Adrenal Tumors) stage, resection status and Ki67 index. T helper cells were negatively correlated with glucocorticoid excess (Phi=-0.290, p=0.009). Patients with glucocorticoid excess and low TILs had a particularly poor overall survival (27 vs. 121 months in patients with TILs without glucocorticoid excess). Conclusion Glucocorticoid excess is associated with T cell depletion and unfavorable prognosis. To reactivate the immune system in ACC by checkpoint inhibitors, an inhibition of adrenal steroidogenesis might be pivotal and should be tested in prospective studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology
    Hiraoka, Nobuyoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (06) : 544 - 551
  • [22] Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma
    Raffone, Antonio
    Travaglino, Antonio
    Raimondo, Diego
    Boccellino, Maria Pia
    Maletta, Manuela
    Borghese, Giulia
    Casadio, Paolo
    Insabato, Luigi
    Mollo, Antonio
    Zullo, Fulvio
    Seracchioli, Renato
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 621 - 628
  • [23] On the Prognostic Power of Tumor-Infiltrating Lymphocytes - A Critical Commentary
    Elkoshi, Zeev
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
    Wongpattaraworakul, Wattawan
    Choi, Allen
    Buchakjian, Marisa R.
    Lanzel, Emily A.
    Rajan, K. D. Anand
    Simons, Andrean L.
    BMC CANCER, 2024, 24 (01)
  • [25] Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma
    Sudo, Tomoya
    Nishida, Ryosuke
    Kawahara, Akihiko
    Saisho, Kouhei
    Mimori, Koshi
    Yamada, Akira
    Mizoguchi, Atsuhi
    Kadoya, Kazutaka
    Matono, Satoru
    Mori, Naoki
    Tanaka, Toshiaki
    Akagi, Yoshito
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3763 - 3770
  • [26] Epigenetic quantification of tumor-infiltrating T-lymphocytes
    Sehouli, Jalid
    Loddenkemper, Christoph
    Cornu, Tatjana
    Schwachula, Tim
    Hoffmueller, Ulrich
    Gruetzkau, Andreas
    Lohneis, Philipp
    Dickhaus, Thorsten
    Groene, Joern
    Kruschewski, Martin
    Mustea, Alexander
    Turbachova, Ivana
    Baron, Udo
    Olek, Sven
    EPIGENETICS, 2011, 6 (02) : 236 - 246
  • [27] Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
    Toss, Michael S.
    Miligy, I.
    Al-Kawaz, Abdubaqi
    Alsleem, Mansour
    Khout, Hazem
    Rida, Padmashree C.
    Aneja, Ritu
    Green, Andrew R.
    Ellis, Ian O.
    Rakha, Emad A.
    MODERN PATHOLOGY, 2018, 31 (08) : 1226 - 1236
  • [28] Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma
    Yao, Chengyun
    Yu, Hongliang
    Zhou, Guoren
    Xu, Jianhua
    Gu, Dayong
    Yin, Li
    He, Xia
    Xia, Hongping
    ESOPHAGUS, 2021, 18 (03) : 574 - 584
  • [29] Tumor-Infiltrating Lymphocytes in Wilms Tumor
    Yadav, Devendra Kumar
    Jain, Vishesh
    Dinda, Amit Kumar
    Agarwala, Sandeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 34 - 38
  • [30] CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma
    Miyasaka, Yuhei
    Yoshimoto, Yuya
    Ando, Ken
    Murata, Kazutoshi
    Irie, Daisuke
    Sato, Hiro
    Noda, Shin-ei
    Ikota, Hayato
    Nakano, Takashi
    Yokoo, Hideaki
    Ohno, Tatsuya
    ANTICANCER RESEARCH, 2023, 43 (05) : 2077 - 2084